Navigation Links
RNA research strategy for Europe takes shape
Date:3/4/2009

Research into RNA, a molecule found in every cell of our bodies, could lead to remarkable advances in the treatment of diseases such as cancer and diabetes, a meeting organised by the European Science Foundation was told.

The conference, held the institute of Parasitologa y Biomedicina "Lpez-Neyra", CSIC in Granada, Spain, on 23 February 2009, was part of an ESF initiative to develop a coherent strategy for RNA research in Europe in recognition of the potential of RNA to result in new approaches to treating human diseases.

For many years it was believed that RNA's sole function in cells was to transmit genetic information from DNA during the manufacture of proteins the cell's workhorse molecules. However, in recent years it has become clear that RNA has many more sophisticated functions and that there are more types of RNA than previously known.

The field exploded into activity with the discovery in 1998 by US researchers Andrew Fire and Craig Mello of a phenomenon called RNA interference, meaning that genes can be 'silenced' by RNA. This discovery, for which Fire and Mello were awarded the Nobel Prize in 2006, revolutionised the way scientists think about how genetic information is controlled in cells, and has opened the possibility of using gene silencing as a therapy where rogue genes cause disease.

"Research into RNA has great promise for both basic science and biotechnology and medicine," said the meeting's chairman, Professor Lars Thelander of Ume University in Sweden. "Most pharmaceutical companies now have RNA projects, but the field is still in its early days and it could be another ten years before we see products appearing in the clinics."

Professor Thomas Cech of the Howard Hughes Medical Institute in the US told the meeting how he discovered that RNA could also act as a biological catalyst something that it was previously thought was the preserve of proteins representing a wonderful example of the versatility of RNA function. The discovery gave rise to new ideas about how life on Earth might have started and resulted in Professor Cech being awarded a Nobel Prize in 1989.

The Granada "Consensus Conference" was organised by ESF as part of a 'Forward Look' entitled 'RNA World: a new frontier in biomedical research' aimed at developing a strategy for research in RNA over the next ten years. Three earlier workshops had examined various aspects of RNA research to identify where gaps in our knowledge lie and what is required to plug these gaps and fulfil the promise that RNA holds. Forward Looks are a key part of ESF's work, examining important areas of science and technology in consultation with leading scientists and policy makers to develop a strategic framework for research.

A Forward Look report on RNA research is due to be published later this year, detailing the scientific questions that need to be answered and giving politicians and policy makers the information they need when deciding where to direct research funding to ensure that Europe remains globally competitive in this key area of emerging science.


'/>"/>

Contact: Sofia Valleley
svalleley@esf.org
33-674-609-687
European Science Foundation
Source:Eurekalert

Related biology news :

1. Research shows skeleton to be endocrine organ
2. Newly created cancer stem cells could aid breast cancer research
3. Dominant cholesterol-metabolism ideas challenged by new research
4. Researchers identify proteins involved in new neurodegenerative syndrome
5. Texas researchers and educators head for Antarctica
6. MGH researchers describe new way to identify, evolve novel enzymes
7. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
8. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
9. U of MN researchers discover noninvasive diagnostic tool for brain diseases
10. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
11. Story ideas from the Journal of Lipid Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed Anwar ... the prestigious international IAIR Award for the most innovative high security ePassport ... ... Maldives Immigration Controller General, Mr. ... on the right) have received the IAIR award for the "Most innovative ...
(Date:3/22/2017)... 21, 2017   Neurotechnology , a provider ... today announced the release of the SentiVeillance ... improved facial recognition using up to 10 surveillance, ... computer. The new version uses deep neural-network-based facial ... it utilizes a Graphing Processing Unit (GPU) for ...
Breaking Biology News(10 mins):
(Date:4/19/2017)... ... 2017 , ... A number of new instruments have recently emerged to accommodate ... Protein and Cell Analysis Education Webinar Series , will focus on advances in ... and future applications. , Many flow cytometers have unique capabilities and the Attune ...
(Date:4/19/2017)... ... April 19, 2017 , ... Nobilis Therapeutics Announces Completion ... to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial , ... patient clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in the treatment ...
(Date:4/19/2017)... ... April 19, 2017 , ... As part of the ... novices as well as experienced users, attendees will gain a better understanding of ... , Hemostasis testing quality is determined by preanalytical variables which encompass patient ...
(Date:4/19/2017)... WESTMINSTER, Colo. , April 19, 2017 /PRNewswire/ ... finance firm that provides senior debt to life ... closing of a $20 million senior secured term ... company engaged in the development and commercialization of ... orthopedic injuries. Cerapedics, lead product, i-FACTOR ...
Breaking Biology Technology: